跳至主要内容
临床试验/RBR-6xbgv9j
RBR-6xbgv9j尚未招募Unknown

Early Coagulation Markers in patients with Visceral Leishmaniasis associated with Tranexamic Acid

Instituto de Doenças Tropicais Nathan Portela - IDTNP0 个研究点开始时间: 2023年4月28日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 0(—)

入选标准

  • Patients with confirmed visceral leishmaniasis; both genders; without age restrictions, who agree to participate voluntarily by signing the Free and Informed Consent Term and the Minor's Assent Term, in patients aged between six and 18 years

排除标准

  • Patients using anticoagulant or antiplatelet medication at the time of admission; recent diagnosis or history of thrombosis at any vascular site; congenital or acquired hemostasis disorders; need for dialysis, surgery or an invasive procedure; known or suspected hypersensitivity to any study drug; recent or past history of seizures; history of dengue fever or Severe Acute Respiratory Syndrome Coronavirus 2 infection in the last 30 days; having received specific anti-Leishmania treatment in the last 90 days; having received antifibrinolytic treatment in the last 48 hours or blood products in the last 360 hours

研究者

发起方
Instituto de Doenças Tropicais Nathan Portela - IDTNP

相似试验